HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Holmberg, K. Articles by Gascoigne, N. R. J. Search for Related Content PubMed PubMed Citation Articles by Holmberg, K. Articles by Gascoigne, N. R. J.

TCR Binding Kinetics Measured with MHC Class I Tetramers Reveal a Positive Selecting Peptide with Relatively High Affinity for TCR ¹

Kaisa Holmberg^*, Sanjeev Mariathasan, Toshiaki Ohteki, Pamela S. Ohashi and Nicholas R. J. Gascoigne^2,*

^* Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037; and Departments of Medical Biophysics and Immunology, UHN, Ontario Cancer Institute, Toronto, Ontario, Canada

The interaction between TCR and peptide-MHC (pMHC) complexes is crucial for the activation of T cells as well as for positive and negative selection in the thymus. The kinetics and affinity of this interaction and the densities of TCR and pMHC complexes on the cell surface are determining factors for different outcomes during thymic selection. In general, it is thought that agonist pMHC, which cause negative selection, have higher affinities and, in particular, slower off-rates than partial or weak agonists and antagonists, which cause positive selection. In this study, we have used pMHC tetramers to investigate the kinetics of TCR-pMHC interaction for agonist, weak agonist, and antagonist ligands of the anti-lymphocytic choriomeningitis virus P14 TCR. Kinetics determined on the cell surface may be biologically more relevant than methods using soluble proteins. We can distinguish between agonists and weak agonists or antagonists based on the half-life and the avidity of tetramer-TCR interaction. Furthermore, we show that a weak agonist self-peptide that positively selects P14 TCR⁺ thymocytes has a tetramer half-life and avidity only slightly weaker than strong agonists. We show that, in fact, it can act as quite a strong agonist, but that its poor ability to stabilize MHC causes it instead to have a weak agonist phenotype.

This article has been cited by other articles:

				J. Kuball, B. Hauptrock, V. Malina, E. Antunes, R.-H. Voss, M. Wolfl, R. Strong, M. Theobald, and P. D. Greenberg Increasing functional avidity of TCR-redirected T cells by removing defined N-glycosylation sites in the TCR constant domain J. Exp. Med., February 16, 2009; 206(2): 463 - 475. [Abstract] [Full Text] [PDF]

				F. Agenes, J.-P. Dangy, and J. Kirberg T cell receptor contact to restricting MHC molecules is a prerequisite for peripheral interclonal T cell competition J. Exp. Med., November 24, 2008; 205(12): 2735 - 2743. [Abstract] [Full Text] [PDF]

				H. A. Wasserman, C. D. Beal, Y. Zhang, N. Jiang, C. Zhu, and B. D. Evavold MHC Variant Peptide-Mediated Anergy of Encephalitogenic T Cells Requires SHP-1 J. Immunol., November 15, 2008; 181(10): 6843 - 6849. [Abstract] [Full Text] [PDF]

				A. Joseph, J. H. Zheng, A. Follenzi, T. DiLorenzo, K. Sango, J. Hyman, K. Chen, A. Piechocka-Trocha, C. Brander, E. Hooijberg, et al. Lentiviral Vectors Encoding Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Receptor Genes Efficiently Convert Peripheral Blood CD8 T Lymphocytes into Cytotoxic T Lymphocytes with Potent In Vitro and In Vivo HIV-1-Specific Inhibitory Activity J. Virol., March 15, 2008; 82(6): 3078 - 3089. [Abstract] [Full Text] [PDF]

				R.-H. Voss, R. A. Willemsen, J. Kuball, M. Grabowski, R. Engel, R. S. Intan, P. Guillaume, P. Romero, C. Huber, and M. Theobald Molecular Design of the C{alpha} Interface Favors Specific Pairing of Introduced TCR{alpha} in Human T Cells J. Immunol., January 1, 2008; 180(1): 391 - 401. [Abstract] [Full Text] [PDF]

				S. Tian, R. Maile, E. J. Collins, and J. A. Frelinger CD8+ T Cell Activation Is Governed by TCR-Peptide/MHC Affinity, Not Dissociation Rate J. Immunol., September 1, 2007; 179(5): 2952 - 2960. [Abstract] [Full Text] [PDF]

				P. R. Hess, C. Barnes, M. D. Woolard, M. D. L. Johnson, J. M. Cullen, E. J. Collins, and J. A. Frelinger Selective deletion of antigen-specific CD8+ T cells by MHC class I tetramers coupled to the type I ribosome-inactivating protein saporin Blood, April 15, 2007; 109(8): 3300 - 3307. [Abstract] [Full Text] [PDF]

				J. W. Hodge, M. Chakraborty, C. Kudo-Saito, C. T. Garnett, and J. Schlom Multiple Costimulatory Modalities Enhance CTL Avidity J. Immunol., May 15, 2005; 174(10): 5994 - 6004. [Abstract] [Full Text] [PDF]

				N. Niederberger, L. K. Buehler, J. Ampudia, and N. R. J. Gascoigne Thymocyte stimulation by anti-TCR-{beta}, but not by anti-TCR-{alpha}, leads to induction of developmental transcription program J. Leukoc. Biol., May 1, 2005; 77(5): 830 - 841. [Abstract] [Full Text] [PDF]

				M. Fridkis-Hareli, P. A. Reche, and E. L. Reinherz Peptide Variants of Viral CTL Epitopes Mediate Positive Selection and Emigration of Ag-Specific Thymocytes In Vivo J. Immunol., July 15, 2004; 173(2): 1140 - 1150. [Abstract] [Full Text] [PDF]

				F. R. Santori, K. Holmberg, D. Ostrov, N. R. J. Gascoigne, and S. Vukmanovic Distinct Footprints of TCR Engagement with Highly Homologous Ligands J. Immunol., June 15, 2004; 172(12): 7466 - 7475. [Abstract] [Full Text] [PDF]